These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21905954)

  • 1. Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive properties.
    Kuçi Z; Kuçi S; Zircher S; Koller S; Schubert R; Bönig H; Henschler R; Lieberz R; Klingebiel T; Bader P
    Cytotherapy; 2011 Nov; 13(10):1193-204. PubMed ID: 21905954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression.
    Kuçi Z; Seiberth J; Latifi-Pupovci H; Wehner S; Stein S; Grez M; Bönig H; Köhl U; Klingebiel T; Bader P; Kuçi S
    Haematologica; 2013 Oct; 98(10):1609-16. PubMed ID: 23975178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells.
    Jarocha D; Lukasiewicz E; Majka M
    Folia Histochem Cytobiol; 2008; 46(3):307-14. PubMed ID: 19056534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction.
    Prevosto C; Zancolli M; Canevali P; Zocchi MR; Poggi A
    Haematologica; 2007 Jul; 92(7):881-8. PubMed ID: 17606437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.
    Kuçi S; Kuçi Z; Kreyenberg H; Deak E; Pütsch K; Huenecke S; Amara C; Koller S; Rettinger E; Grez M; Koehl U; Latifi-Pupovci H; Henschler R; Tonn T; von Laer D; Klingebiel T; Bader P
    Haematologica; 2010 Apr; 95(4):651-9. PubMed ID: 20179086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.
    English K; Ryan JM; Tobin L; Murphy MJ; Barry FP; Mahon BP
    Clin Exp Immunol; 2009 Apr; 156(1):149-60. PubMed ID: 19210524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
    Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
    Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems.
    Demircan PC; Sariboyaci AE; Unal ZS; Gacar G; Subasi C; Karaoz E
    Cytotherapy; 2011 Nov; 13(10):1205-20. PubMed ID: 21905956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel markers for the prospective isolation of human MSC.
    Bühring HJ; Battula VL; Treml S; Schewe B; Kanz L; Vogel W
    Ann N Y Acad Sci; 2007 Jun; 1106():262-71. PubMed ID: 17395729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
    Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression.
    Yang HM; Sung JH; Choi YS; Lee HJ; Roh CR; Kim J; Shin M; Song S; Kwon CH; Joh JW; Kim SJ
    Cytotherapy; 2012 Jan; 14(1):70-9. PubMed ID: 21954834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory Properties of Induced Pluripotent Stem Cell-Derived Mesenchymal Cells.
    Ng J; Hynes K; White G; Sivanathan KN; Vandyke K; Bartold PM; Gronthos S
    J Cell Biochem; 2016 Dec; 117(12):2844-2853. PubMed ID: 27167148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine.
    Sangiorgi B; De Freitas HT; Schiavinato JL; Leão V; Haddad R; Orellana MD; Faça VM; Ferreira GA; Covas DT; Zago MA; Panepucci RA
    Cytotherapy; 2016 Jul; 18(7):846-59. PubMed ID: 27260206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro migration and proliferation ("wound healing") potential of mesenchymal stromal cells generated from human CD271(+) bone marrow mononuclear cells.
    Latifi-Pupovci H; Kuçi Z; Wehner S; Bönig H; Lieberz R; Klingebiel T; Bader P; Kuçi S
    J Transl Med; 2015 Sep; 13():315. PubMed ID: 26407865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential.
    Rizzo R; Lanzoni G; Stignani M; Campioni D; Alviano F; Ricci F; Tazzari PL; Melchiorri L; Scalinci SZ; Cuneo A; Bonsi L; Lanza F; Bagnara GP; Baricordi OR
    Cytotherapy; 2011 May; 13(5):523-7. PubMed ID: 21171826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells.
    Ryan JM; Barry F; Murphy JM; Mahon BP
    Clin Exp Immunol; 2007 Aug; 149(2):353-63. PubMed ID: 17521318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow mesenchymal stem cells suppressing activation of allogeneic cytokine-induced killer/natural killer cells either by direct or indirect interaction.
    Li Y; Qu YH; Wu YF; Liu L; Lin XH; Huang K; Wei J
    Cell Biol Int; 2015 Apr; 39(4):435-45. PubMed ID: 25492047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of the CD271+ and CD271- mesenchymal stromal cell enrichment toward nucleus pulposus-like cells.
    Jezierska-Wozniak K; Barczewska M; Habich A; Wojtacha P; Badowska W; Maksymowicz W; Wojtkiewicz J
    Folia Histochem Cytobiol; 2017; 55(3):114-123. PubMed ID: 28925497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells.
    Hegyi B; Kudlik G; Monostori E; Uher F
    Biochem Biophys Res Commun; 2012 Mar; 419(2):215-20. PubMed ID: 22333568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
    Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
    Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.